Pioneer Group: Investment Portfolio & Startup News
Pioneer Group
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
NunaBio raises £6.5m led by Northstar Ventures to manufacture high fidelity synthetic DNA at scale
NunaBio develops an enzymatic DNA synthesis platform that manufactures high fidelity synthetic DNA at scale. The platform enables customers in sectors such as medicine, biotechnology and diagnostics to access complex DNA formats that are difficult to produce using traditional methods.
NuVision Biotherapies unlocks £4.8m in funding led by Mercia Ventures to speed up the healing of eye conditions
NuVision Biotherapies develops ophthalmic products based on amniotic membrane tissue. Its treatments are used to support healing after eye surgery and manage chronic eye conditions.
ImmuONE raises £600k follow-on from investors to expand 3D lung model as an alternative to animal testing
ImmuONE provides a 3D human lung laboratory model that replaces animal testing, allowing companies to assess respiratory safety, inflammation and long-term effects of chemicals, drugs and consumer products more reliably.
More venture news
- 30 Sept 2026
ZenithonZenithon raises a £7.5m seed round led by BACKED for ML models that solves complex physics
EquityDeep Tech - 30 Sept 2026
Inovus MedicalInovus Medical lands £7m extension led by PXN Group to provide surgeons with surgical simulation training
EquityHealth - 29 Sept 2026
Something & NothingSomething & Nothing unlocks £5m in funding led by Venrex for premium soft drinks built on flavour
EquityConsumer
